hydroxyindoleacetic acid has been researched along with Cancer of Gastrointestinal Tract in 51 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urinary 5-hydroxyindoleacetic acid (5-HIAA) is an established biomarker in neuroendocrine tumors and carcinoid syndrome; however, its role in nonfunctional neuroendocrine tumors is not defined." | 9.30 | Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. ( Fisher, GA; Liyanage, N; Mirakhur, B; Pavel, ME; Phan, AT; Pitman Lowenthal, S; Vinik, AI; Wolin, EM, 2019) |
| "The urinary excretion of 5-hydroxyindoleacetic acid, 5-hydroxytryptophan, serotonin, tryptamine, and tyramine and the serum serotonin concentration were determined in 38 consecutive patients with metastatic carcinoid tumors." | 7.66 | Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. ( Feldman, JM, 1978) |
| "Urinary 5-hydroxyindoleacetic acid (5-HIAA) is an established biomarker in neuroendocrine tumors and carcinoid syndrome; however, its role in nonfunctional neuroendocrine tumors is not defined." | 5.30 | Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. ( Fisher, GA; Liyanage, N; Mirakhur, B; Pavel, ME; Phan, AT; Pitman Lowenthal, S; Vinik, AI; Wolin, EM, 2019) |
| " The number and intensity of flushing episodes and bowel movements, urinary 5-hydroxyindoleacetic acid (5HIAA) levels, and plasma serotonin levels were recorded." | 5.09 | Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. ( Blumberg, J; Bommelaer, G; Bouché, O; Catus, F; Ducreux, M; O'Toole, D; Ruszniewski, P; Wemeau, JL, 2000) |
| " PCPA (2 g 8 hourly for 2 or 3 days prior to cisplatin) reduced the spontaneous urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA), inhibited the increase in urinary 5-HIAA induced by cisplatin and markedly attenuated the acute period of nausea and vomiting associated with the cytotoxic drug." | 5.08 | Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients. ( Alfieri, AB; Cubeddu, LX, 1995) |
| " Carcinoid tumors with liver metastases, especially those of midgut origin, produce serotonin via the precursors tryptophan and 5-hydroxytryptophan (5-HTP) and this overproduction contributes to the clinical symptoms of the carcinoid syndrome." | 5.07 | Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors. ( Ahlström, H; Bergström, M; Eriksson, B; Långström, B; Lilja, A; Oberg, K, 1993) |
| "Previously we observed in patients suffering from a metastatic carcinoid tumor that irritability, aggression and lack of impulse control are associated with low levels of plasma tryptophan and presumably with low brain serotonin function." | 3.74 | Low plasma tryptophan in carcinoid patients is associated with increased urinary cortisol excretion. ( De Vries, EG; Dijck-Brouwer, J; Doornbos, B; Kema, IP; Korf, J; Tanke, MA, 2008) |
| "The urinary excretion of 5-hydroxyindoleacetic acid, 5-hydroxytryptophan, serotonin, tryptamine, and tyramine and the serum serotonin concentration were determined in 38 consecutive patients with metastatic carcinoid tumors." | 3.66 | Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. ( Feldman, JM, 1978) |
| "Midgut carcinoid tumours often present with widespread disease making curative surgery impossible." | 2.71 | Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours. ( Ahrén, B; Franzén, S; Kölby, L; Persson, G, 2003) |
| "Twenty-one patients with metastatic carcinoid tumors were treated with docetaxel." | 2.71 | A phase II study of docetaxel in patients with metastatic carcinoid tumors. ( Clark, JW; Fuchs, CS; Kim, H; Kulke, MH; Mayer, RJ; Ryan, DP; Stuart, K; Vincitore, M, 2004) |
| "Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for other disorders initially." | 2.53 | Neuroendocrine Tumors. ( Basuroy, R; Ramage, JK; Srirajaskanthan, R, 2016) |
| "Carcinoid tumors are amine precursor uptake decarboxylase (APUD) omas that arise from enterochromaffin cells throughout the gut." | 2.45 | Carcinoid tumors of the gastrointestinal tract. ( Anand, S; Ghevariya, N; Ghevariya, V; Malieckal, A; Mazumder, M, 2009) |
| "Carcinoid tumors are rare, often insidious neoplasms arising from neuroendocrine cells." | 2.43 | Gastrointestinal carcinoids: the evolution of diagnostic strategies. ( Chan, AK; Eick, G; Kidd, M; Latich, I; Modlin, IM; Zikusoka, M, 2006) |
| "Patients with carcinoid tumours require a multidisciplinary approach to their care." | 2.41 | Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary. ( DiFrancesco, LM; Kinnear, S; McEwan, A; McKinnon, JG; Numerow, L; Pasieka, JL; Paterson, A; Rorstad, O; Skogseid, B; Yelle, CA, 2001) |
| "90% of all carcinoids originate from enterochromaffine cells in the GIT." | 1.32 | [Pitfalls in the diagnosis of carcinoids in patients treated with aminosalicylates]. ( Cáslavský, J; Chmelík, J; Dastych, M; Senkyrík, M; Starý, K; Zboril, V, 2003) |
| "A prospective database of carcinoid patients seen at Duke University Medical Center was kept from 1970 to the present." | 1.31 | Gastrointestinal carcinoids: characterization by site of origin and hormone production. ( Feldman, JM; Hayward, TZ; Kirshbom, PM; Onaitis, MW; Quayle, FJ; Seigler, HF; Tyler, DS, 2000) |
| "Gastrointestinal foregut carcinoids make up a small percentage (3% to 6%) of all reported carcinoids." | 1.30 | Foregut carcinoids: a clinical and biochemical analysis. ( Feldman, C; Feldman, JM; Hata, A; Kehoe, TE; Kherani, AR; Kirshbom, PM; Onaitis, MW; Tyler, DS, 1999) |
| "Seven patients with metastasized midgut carcinoids were treated with intravenous infusion of dacarbazine [dimethyltriazenoimidazole carboxamide (DTIC)] (650 mg/m2) every 4 wk." | 1.29 | Treatment of metastasized midgut carcinoids with dacarbazine. ( Leonhardt, U; Ramadori, G; Ritzel, U; Stöckmann, F, 1995) |
| "5-HT apudomas are rare." | 1.28 | [The application of 5-HT and 5-HIAA in the diagnosis of apudomas]. ( Chen, HC; Chen, YF; Xu, SH, 1990) |
| "Seventeen patients with malignant carcinoid tumour, ten of whom had the malignant carcinoid syndrome, were treated with recombinant alpha-2b interferon by subcutaneous injection (3 MU per dose) three times per week for a median of 12 weeks (range 4-48)." | 1.28 | Recombinant alpha-2b interferon in patients with malignant carcinoid tumour. ( Basser, RL; Fox, RM; Green, MD; Lieschke, GJ; Sheridan, WP, 1991) |
| "Calcium infusion induced carcinoid symptoms in only two of six patients, which were associated with elevated 5-HT levels (whereas elevated SP levels were seen in only one patient)." | 1.27 | The pentagastrin test in the diagnosis of the carcinoid syndrome. ( Ahlman, H; Dahlström, A; Grönstad, K; Jaffe, BM; Nilsson, O; Oberg, K, 1985) |
| "Twelve carcinoid patients and six controls were given alcohol and the kallikrein activity was measured before and at 2, 5, and 10 minutes after alcohol ingestion; kallikrein activity did not change significantly." | 1.27 | Flushing in the carcinoid syndrome and plasma kallikrein. ( Feldman, JM; Lucas, KJ, 1986) |
| "Of 49 patients with midgut and hindgut carcinoids, second primary distinct carcinomas occurred in 12." | 1.26 | Gastrointestinal carcinoids: extrahepatic metastases and symptomatology following resection. ( Dilawari, RA; Douglass, HO, 1979) |
| "These arthropathies have been the subject of only a very limited number of publications." | 1.26 | [Joint manifestations of carcinoid tumors of the digestive system]. ( Solnica, J, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (29.41) | 18.7374 |
| 1990's | 11 (21.57) | 18.2507 |
| 2000's | 16 (31.37) | 29.6817 |
| 2010's | 8 (15.69) | 24.3611 |
| 2020's | 1 (1.96) | 2.80 |
| Authors | Studies |
|---|---|
| de Mestier, L | 1 |
| Savagner, F | 1 |
| Brixi, H | 1 |
| Do Cao, C | 1 |
| Dominguez-Tinajero, S | 1 |
| Roquin, G | 1 |
| Goichot, B | 1 |
| Hentic, O | 1 |
| Dubreuil, O | 1 |
| Hautefeuille, V | 1 |
| Walter, T | 1 |
| Cadiot, G | 1 |
| Rodríguez Laval, V | 1 |
| Pavel, M | 1 |
| Steffen, IG | 1 |
| Baur, AD | 1 |
| Dilz, LM | 1 |
| Fischer, C | 1 |
| Detjen, K | 1 |
| Prasad, V | 1 |
| Pascher, A | 1 |
| Geisel, D | 1 |
| Denecke, T | 1 |
| Pavel, ME | 1 |
| Phan, AT | 1 |
| Wolin, EM | 1 |
| Mirakhur, B | 1 |
| Liyanage, N | 1 |
| Pitman Lowenthal, S | 1 |
| Fisher, GA | 1 |
| Vinik, AI | 1 |
| Kinová, S | 1 |
| Kovácová, M | 1 |
| Caprnda, M | 1 |
| Koren, M | 1 |
| Zandee, WT | 1 |
| Kamp, K | 1 |
| van Adrichem, RC | 1 |
| Feelders, RA | 1 |
| de Herder, WW | 2 |
| Basuroy, R | 1 |
| Srirajaskanthan, R | 1 |
| Ramage, JK | 1 |
| Tanke, MA | 1 |
| Kema, IP | 1 |
| Dijck-Brouwer, J | 1 |
| Doornbos, B | 1 |
| De Vries, EG | 1 |
| Korf, J | 1 |
| Korse, CM | 1 |
| Bonfrer, JM | 1 |
| Aaronson, NK | 1 |
| Hart, AA | 1 |
| Taal, BG | 1 |
| Ghevariya, V | 1 |
| Malieckal, A | 1 |
| Ghevariya, N | 1 |
| Mazumder, M | 1 |
| Anand, S | 1 |
| Berković, MC | 1 |
| Jokić, M | 1 |
| Marout, J | 1 |
| Radosević, S | 1 |
| Zjacić-Rotkvić, V | 1 |
| Kapitanović, S | 1 |
| Pregun, I | 1 |
| Bodoky, G | 1 |
| Rácz, K | 1 |
| Tulassay, Z | 1 |
| Eapen, DJ | 1 |
| Clements, S | 1 |
| Block, P | 1 |
| Sperling, L | 1 |
| Piette, C | 1 |
| Polus, M | 1 |
| Louis, E | 1 |
| Dastych, M | 2 |
| Zboril, V | 1 |
| Senkyrík, M | 1 |
| Starý, K | 1 |
| Cáslavský, J | 1 |
| Chmelík, J | 1 |
| Kölby, L | 1 |
| Persson, G | 1 |
| Franzén, S | 1 |
| Ahrén, B | 1 |
| Kulke, MH | 1 |
| Kim, H | 1 |
| Stuart, K | 1 |
| Clark, JW | 1 |
| Ryan, DP | 1 |
| Vincitore, M | 1 |
| Mayer, RJ | 1 |
| Fuchs, CS | 1 |
| Rorstad, O | 2 |
| Shah, GM | 1 |
| Shah, RG | 1 |
| Veillette, H | 1 |
| Kirkland, JB | 1 |
| Pasieka, JL | 2 |
| Warner, RR | 1 |
| van der Lely, AJ | 1 |
| Modlin, IM | 1 |
| Latich, I | 1 |
| Zikusoka, M | 1 |
| Kidd, M | 1 |
| Eick, G | 1 |
| Chan, AK | 1 |
| Formica, V | 1 |
| Wotherspoon, A | 1 |
| Cunningham, D | 1 |
| Norman, AR | 1 |
| Sirohi, B | 1 |
| Oates, J | 1 |
| Chong, G | 1 |
| Keane, TJ | 1 |
| Rider, WD | 1 |
| Harwood, AR | 1 |
| Thomas, GM | 1 |
| Cummings, BJ | 1 |
| Aleshire, SL | 1 |
| Bradley, CA | 1 |
| Parl, FF | 1 |
| Nold, R | 1 |
| Frank, M | 1 |
| Kajdan, U | 1 |
| Trost, U | 1 |
| Klose, KJ | 1 |
| Arnold, R | 1 |
| Alfieri, AB | 1 |
| Cubeddu, LX | 1 |
| Jacobsen, MB | 1 |
| Hanssen, LE | 1 |
| Ritzel, U | 1 |
| Leonhardt, U | 1 |
| Stöckmann, F | 2 |
| Ramadori, G | 1 |
| Eriksson, B | 1 |
| Bergström, M | 1 |
| Lilja, A | 1 |
| Ahlström, H | 1 |
| Långström, B | 1 |
| Oberg, K | 3 |
| Ahlman, H | 2 |
| Kirshbom, PM | 2 |
| Kherani, AR | 1 |
| Onaitis, MW | 2 |
| Hata, A | 1 |
| Kehoe, TE | 1 |
| Feldman, C | 1 |
| Feldman, JM | 4 |
| Tyler, DS | 2 |
| O'Toole, D | 1 |
| Ducreux, M | 1 |
| Bommelaer, G | 1 |
| Wemeau, JL | 1 |
| Bouché, O | 1 |
| Catus, F | 1 |
| Blumberg, J | 1 |
| Ruszniewski, P | 1 |
| Lee, MS | 1 |
| Cheng, FC | 1 |
| Yeh, HZ | 1 |
| Liou, TY | 1 |
| Liu, JH | 1 |
| Hayward, TZ | 1 |
| Quayle, FJ | 1 |
| Seigler, HF | 1 |
| McKinnon, JG | 1 |
| Kinnear, S | 1 |
| Yelle, CA | 1 |
| Numerow, L | 1 |
| Paterson, A | 1 |
| DiFrancesco, LM | 1 |
| McEwan, A | 1 |
| Skogseid, B | 1 |
| Hoberock, TR | 1 |
| Knutson, CO | 1 |
| Polk, HC | 1 |
| Dilawari, RA | 1 |
| Douglass, HO | 1 |
| Solnica, J | 1 |
| Xu, SH | 1 |
| Chen, YF | 1 |
| Chen, HC | 1 |
| Agranovich, AL | 1 |
| Anderson, GH | 1 |
| Manji, M | 1 |
| Acker, BD | 1 |
| Macdonald, WC | 1 |
| Threlfall, WJ | 1 |
| Creutzfeldt, W | 1 |
| Bartsch, HH | 1 |
| Jacubaschke, U | 1 |
| Basser, RL | 1 |
| Lieschke, GJ | 1 |
| Sheridan, WP | 1 |
| Fox, RM | 1 |
| Green, MD | 1 |
| Dahlström, A | 1 |
| Grönstad, K | 1 |
| Jaffe, BM | 1 |
| Nilsson, O | 1 |
| Wang, BT | 1 |
| Yan, NS | 1 |
| Chen, SJ | 1 |
| Lucas, KJ | 1 |
| Berstad, T | 1 |
| Bergan, A | 1 |
| Flatmark, A | 1 |
| Norheim, I | 1 |
| Theodorsson-Norheim, E | 1 |
| Lindgren, PG | 1 |
| Lundqvist, G | 1 |
| Magnusson, A | 1 |
| Wide, L | 1 |
| Wilander, E | 1 |
| Soga, J | 1 |
| Tazawa, K | 1 |
| Hermanutz, KD | 1 |
| Bücheler, E | 1 |
| Biersack, HJ | 1 |
| Ryss, ES | 1 |
| Luschnitz, E | 1 |
| Oliva, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors[NCT02826928] | 116 participants (Actual) | Interventional | 2016-10-26 | Completed | |||
| 68Ga-DOTATATE Imaging in Neuroendocrine Tumors[NCT02174679] | 0 participants | Expanded Access | No longer available | ||||
| Safety of Lanreotide 120 mg ATG in Combination With Metformin in Patients With Progressive Advanced Well-differentiated Gastro-intestinal (GI) or Lung Carcinoids: A Pilot, One-arm, Open-label, Prospective Study: the MetNET-2 Trial[NCT02823691] | Early Phase 1 | 20 participants (Actual) | Interventional | 2016-04-30 | Active, not recruiting | ||
| UPCC 04219 Phase 2 Study of Capecitabine-Temozolomide(CapTem) With Yttrium-90 Radioembolization in the Treatment of Patients With Unresectable Metastatic Grade 2 Neuroendocrine Tumors[NCT04339036] | Phase 2 | 50 participants (Anticipated) | Interventional | 2021-10-07 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for hydroxyindoleacetic acid and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Neuroendocrine Tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Chromogranin A; Digestive System Surgical Pr | 2016 |
Carcinoid tumors of the gastrointestinal tract.
Topics: Antineoplastic Agents; Carcinoid Tumor; Chemoembolization, Therapeutic; Chromogranins; Diagnostic Im | 2009 |
[Carcinoid tumors].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biomarkers, Tumor; Bronchial Neoplasms; Carcinoid Tumo | 2010 |
[Pathological implications in the neuroendocrine gastrointestinal system].
Topics: Carcinoid Tumor; Combined Modality Therapy; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic | 2002 |
Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Topics: Biomarkers, Tumor; Carcinoid Heart Disease; Carcinoid Tumor; Chromogranin A; Chromogranins; Gastroin | 2005 |
Carcinoid syndrome: diagnosis and medical management.
Topics: Biomarkers, Tumor; Chromogranin A; Chromogranins; Gastrointestinal Neoplasms; Humans; Hydroxyindolea | 2005 |
Gastrointestinal carcinoids: the evolution of diagnostic strategies.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Capsule Endoscopy; Carcino | 2006 |
The carcinoid syndrome: neuroendocrine and chemical considerations.
Topics: Endocrine Glands; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Kinins; Malignant Ca | 1984 |
Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary.
Topics: Algorithms; Appendiceal Neoplasms; Carcinoid Tumor; Gastrointestinal Neoplasms; Humans; Hydroxyindol | 2001 |
[Current views on carcinoid and the carcinoid syndrome].
Topics: 1-Propanol; 5-Hydroxytryptophan; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Carcinoi | 1971 |
10 trials available for hydroxyindoleacetic acid and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Chromogranin A; Female; Fo | 2019 |
Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Carcinoid Tumor; Disease Progression; Fema | 2003 |
A phase II study of docetaxel in patients with metastatic carcinoid tumors.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carc | 2004 |
Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fenclonine; Gastrointestin | 1995 |
Clinical effects of octreotide compared to placebo in patients with gastrointestinal neuroendocrine tumours. Report on a double-blind, randomized trial.
Topics: Adaptation, Psychological; Adult; Aged; Biomarkers, Tumor; Double-Blind Method; Female; Gastrointest | 1995 |
Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors.
Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Carbon Radioisotopes; Carcinoid Tumor; Female; Gastrointes | 1993 |
The role of surgery in patients with advanced midgut carcinoid tumours.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Carcinoid Tumor; Combined Modality Therapy; Female; Ga | 1996 |
Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoid Tumor; Cross-Over Studies; Diarrhea; Female; Flu | 2000 |
Determination of plasma serotonin and 5-hydroxyindoleacetic acid in healthy subjects and cancer patients.
Topics: Adult; Aged; Chromatography, Liquid; Electrochemistry; Female; Gastrointestinal Neoplasms; Humans; H | 2000 |
Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide.
Topics: Aged; Carcinoid Tumor; Drug Evaluation; Female; Gastrinoma; Gastrointestinal Neoplasms; Humans; Hydr | 1991 |
31 other studies available for hydroxyindoleacetic acid and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study.
Topics: Aged; Biomarkers, Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Male; | 2021 |
Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
Topics: Aged; Cohort Studies; Female; Fibrosis; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid | 2018 |
[Management of treatment in patients with neuroendocrine neoplasmas of digestive tract].
Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Chromogranin A; Endoscopy, Digestive System; Female | 2015 |
Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours.
Topics: Aged; Biomarkers, Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Male; | 2016 |
Low plasma tryptophan in carcinoid patients is associated with increased urinary cortisol excretion.
Topics: Brain; Carcinoid Tumor; Gastrointestinal Neoplasms; Humans; Hydrocortisone; Hydroxyindoleacetic Acid | 2008 |
Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoid Tumor; Chromogranin A; Female; Follow-U | 2009 |
IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).
Topics: Adult; Aged; Alleles; Biomarkers, Tumor; Cytokines; Female; Gastrointestinal Neoplasms; Genetic Pred | 2010 |
Metastatic carcinoid disease inducing coronary vasospasm.
Topics: Aged; Alcohol Drinking; Antineoplastic Agents, Hormonal; Biomarkers; Carcinoid Heart Disease; Carcin | 2012 |
[Pitfalls in the diagnosis of carcinoids in patients treated with aminosalicylates].
Topics: Adult; Aminosalicylic Acids; Biomarkers, Tumor; Carcinoid Tumor; Chromatography, High Pressure Liqui | 2003 |
Biochemical assessment of niacin deficiency among carcinoid cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Case-Control Studies; Cohort Studies; Female; Gastr | 2005 |
The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleace | 2007 |
Whole abdominal radiation in the management of metastatic gastrointestinal carcinoid tumor.
Topics: Abdomen; Adult; Aged; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacet | 1981 |
[Combined treatment of metastatic endocrine tumors of the gastrointestinal tract with octreotide and interferon-alpha].
Topics: Biomarkers, Tumor; Combined Modality Therapy; Female; Gastrinoma; Gastrins; Gastrointestinal Neoplas | 1994 |
Treatment of metastasized midgut carcinoids with dacarbazine.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoid Tumor; Dacarbazine; Drug Administration Schedule; Female; | 1995 |
Foregut carcinoids: a clinical and biochemical analysis.
Topics: Adult; Age Distribution; Aged; Analysis of Variance; Carcinoid Tumor; Duodenal Neoplasms; Female; Ga | 1999 |
Gastrointestinal carcinoids: characterization by site of origin and hormone production.
Topics: Carcinoid Tumor; Databases, Factual; Female; Gastrointestinal Neoplasms; Hormones, Ectopic; Humans; | 2000 |
Clinical aspects of invasive carcinoid tumors.
Topics: Adolescent; Adult; Aged; Biopsy; Bronchoscopy; Carcinoid Tumor; Child; Female; Follow-Up Studies; Ga | 1975 |
Gastrointestinal carcinoids: extrahepatic metastases and symptomatology following resection.
Topics: Adolescent; Adult; Aged; Appendiceal Neoplasms; Carcinoid Tumor; Child; Female; Gastrointestinal Neo | 1979 |
Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors.
Topics: 5-Hydroxytryptophan; Adult; Aged; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydro | 1978 |
[Joint manifestations of carcinoid tumors of the digestive system].
Topics: Finger Joint; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Joint Diseases; Malignan | 1976 |
[The application of 5-HT and 5-HIAA in the diagnosis of apudomas].
Topics: Adolescent; Adult; Aged; Apudoma; Carcinoid Tumor; Carcinoma, Small Cell; Female; Gastrointestinal N | 1990 |
Carcinoid tumour of the gastrointestinal tract: prognostic factors and disease outcome.
Topics: Adult; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Male; | 1991 |
Recombinant alpha-2b interferon in patients with malignant carcinoid tumour.
Topics: Adult; Aged; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; | 1991 |
The pentagastrin test in the diagnosis of the carcinoid syndrome.
Topics: Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Ketanserin; M | 1985 |
[Carcinoid tumors of the gastrointestinal tract].
Topics: Adult; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Male; | 1985 |
Flushing in the carcinoid syndrome and plasma kallikrein.
Topics: Adult; Aged; Bronchial Neoplasms; Carcinoid Tumor; Female; Flushing; Gastrointestinal Neoplasms; Hum | 1986 |
[Carcinoid tumors of the gastrointestinal tract. Surgical treatment].
Topics: Adult; Aged; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; | 1986 |
Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival.
Topics: Adult; Aged; Bronchial Neoplasms; Diarrhea; Female; Flushing; Gastrointestinal Neoplasms; Heart Arre | 1987 |
Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases.
Topics: 5-Hydroxytryptophan; Carcinoid Tumor; Cytoplasmic Granules; Gastrointestinal Neoplasms; Histamine; H | 1971 |
[The radiological diagnosis of carcinoids (author's transl)].
Topics: Angiography; Carcinoid Tumor; Cecal Neoplasms; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacet | 1974 |
[Test meal for the determination of 5-hydroxyindoleacetic acid in urine].
Topics: Carcinoid Tumor; Diet; Food Analysis; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; | 1967 |